157 results
8-K
EX-99.1
r3pds crb6
13 Mar 24
Coherus BioSciences Reports Fourth Quarter, Full Year 2023 Financial Results and Provides Current Business Update
4:16pm
8-K
EX-99.1
yvtpkvb3pem
4 Mar 24
Completion of Acquisition or Disposition of Assets
6:22am
8-K
EX-99.1
ju7fjnmsp
5 Feb 24
Coherus Amends Term Loan Agreement with Pharmakon Advisors, LP
8:09am
8-K
EX-2.1
rswg pbqptdp4
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
8-K
EX-99.1
mxeovfqcx phmx3h2
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
8-K
lbw29o kxizv
26 Dec 23
Other Events
8:49pm
8-K
EX-99.1
doms4
6 Nov 23
Coherus BioSciences Reports Third Quarter 2023 Financial Results and Business Highlights
4:31pm
8-K
EX-99.1
ddu1j ls3lj
27 Oct 23
Regulation FD Disclosure
4:19pm
424B5
szz r2nxxw
12 Sep 23
Prospectus supplement for primary offering
6:04am
8-K
EX-99.1
q632tn
8 Sep 23
Coherus Completes Surface Oncology Acquisition
9:12am